BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27683104)

  • 1. Iatrogenic Menopause After Treatment for Cervical Cancer.
    Moss EL; Taneja S; Munir F; Kent C; Robinson L; Potdar N; Sarhanis P; McDermott H
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):766-775. PubMed ID: 27683104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Rauh LA; Pannone AF; Cantrell LA
    Gynecol Oncol; 2017 Dec; 147(3):597-600. PubMed ID: 28923411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
    van der Hoef C; Bawuah Dsane L; Schuur N; Louwers YV; Mens JW; Hikary-Bhal N; van Doorn HC
    Maturitas; 2024 Jul; 185():108004. PubMed ID: 38663162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Climacteric: concept, consequence and care.
    Taechakraichana N; Jaisamrarn U; Panyakhamlerd K; Chaikittisilpa S; Limpaphayom KK
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S1-15. PubMed ID: 12188398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and cervical cancer: a systematic review of the literature.
    Vargiu V; Amar ID; Rosati A; Dinoi G; Turco LC; Capozzi VA; Scambia G; Villa P
    Climacteric; 2021 Apr; 24(2):120-127. PubMed ID: 33236658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and women with premature menopause--a cancer survivorship issue.
    King J; Wynne CH; Assersohn L; Jones A
    Eur J Cancer; 2011 Jul; 47(11):1623-32. PubMed ID: 21561765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women's perceptions of hormone replacement therapy: risks and benefits (1980-2002). A literature review.
    Buick DL; Crook D; Horne R
    Climacteric; 2005 Mar; 8(1):24-35. PubMed ID: 15804729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coping with menopausal symptoms: An internet survey of Belgian postmenopausal women.
    Depypere H; Pintiaux A; Desreux J; Hendrickx M; Neven P; Marchowicz E; Albert V; Leclercq V; Van den Branden S; Rozenberg S
    Maturitas; 2016 Aug; 90():24-30. PubMed ID: 27282790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's knowledge about menopause, hormone replacement therapy (HRT), and interactions with healthcare providers: an exploratory study.
    Clinkingbeard C; Minton BA; Davis J; McDermott K
    J Womens Health Gend Based Med; 1999 Oct; 8(8):1097-102. PubMed ID: 10565668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause.
    Suzuki Y; Huang Y; Ferris J; Kulkarni A; Hershman D; Wright JD
    Int J Gynecol Cancer; 2023 Jan; 33(1):26-34. PubMed ID: 36543392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
    MacDougall LA; Barzilay JI; Helmick CG
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal symptoms after the discontinuation of long-term hormone replacement therapy in women under 60: a 3-year follow-up.
    Perrone G; Capri O; Galoppi P; Patacchioli FR; Bevilacqua E; de Stefano MG; Brunelli R
    Gynecol Obstet Invest; 2013; 76(1):38-43. PubMed ID: 23711663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
    Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
    Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopause, hormone replacement and gynaecological cancers.
    Hinds L; Price J
    Menopause Int; 2010 Jun; 16(2):89-93. PubMed ID: 20729501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy use and menopausal symptoms among women participating in a behavioral lifestyle intervention.
    Boraz MA; Simkin-Silverman LR; Wing RR; Meilahn EN; Kuller LH
    Prev Med; 2001 Aug; 33(2 Pt 1):108-14. PubMed ID: 11493043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant fall in hormone replacement therapy prescription in general practice.
    Lagro-Janssen A; Knufing MW; Schreurs L; van Weel C
    Fam Pract; 2010 Aug; 27(4):424-9. PubMed ID: 20406789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why menopausal women do not want to take hormone replacement therapy.
    Rabin DS; Cipparrone N; Linn ES; Moen M
    Menopause; 1999; 6(1):61-7. PubMed ID: 10100182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evidence base for HRT: what can we believe?
    Langer RD
    Climacteric; 2017 Apr; 20(2):91-96. PubMed ID: 28281363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.